108 related articles for article (PubMed ID: 9815773)
21. p53 and microvessel density in primary resection specimens of superficial bladder cancer.
Reiher F; Ozer O; Pins M; Jovanovic BD; Eggener S; Campbell SC
J Urol; 2002 Mar; 167(3):1469-74. PubMed ID: 11832772
[TBL] [Abstract][Full Text] [Related]
22. Thymidine phosphorylase activity in renal cell carcinoma: relationship between histological parameters and chemosensitivity to fluorouracil-related drugs.
Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Urol Res; 2002 May; 30(2):112-5. PubMed ID: 12086015
[TBL] [Abstract][Full Text] [Related]
23. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5'-DFUR and OK-432 on cytokines and thymidine phosphorylase in tumor tissue of gastric cancer patients.
Ohwada S; Ogawa T; Izumi M; Inoue T; Teshigawara O; Ikeya T; Kusaba T; Roppongi T; Iino Y; Morishita Y
Anticancer Res; 1997; 17(3C):2313-8. PubMed ID: 9216708
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of thymidine kinase activity in bladder carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Kamoi K; Miki T
Cancer; 2002 Nov; 95(10):2120-5. PubMed ID: 12412165
[TBL] [Abstract][Full Text] [Related]
26. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
[TBL] [Abstract][Full Text] [Related]
27. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
[TBL] [Abstract][Full Text] [Related]
28. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
29. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
Crew JP; Fuggle S; Bicknell R; Cranston DW; de Benedetti A; Harris AL
Br J Cancer; 2000 Jan; 82(1):161-6. PubMed ID: 10638984
[TBL] [Abstract][Full Text] [Related]
30. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
[TBL] [Abstract][Full Text] [Related]
31. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C
Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
[TBL] [Abstract][Full Text] [Related]
32. Bladder tissue pharmacokinetics and antitumor effect of intravesical 5-fluorouridine.
Song D; Wientjes MG; Gan Y; Au JL
Clin Cancer Res; 1997 Jun; 3(6):901-9. PubMed ID: 9815765
[TBL] [Abstract][Full Text] [Related]
33. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.
Oliveira-Ferrer L; Tilki D; Ziegeler G; Hauschild J; Loges S; Irmak S; Kilic E; Huland H; Friedrich M; Ergün S
Cancer Res; 2004 Dec; 64(24):8932-8. PubMed ID: 15604255
[TBL] [Abstract][Full Text] [Related]
34. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
Nozawa T; Enomoto T; Koshida Y; Sato Y; Kuranami M
Dis Colon Rectum; 2004 Dec; 47(12):2093-100. PubMed ID: 15657660
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic conversion of 5-fluoro-2'-deoxyuridine to 5-fluorouracil or 5-fluoro-2'-deoxyuridine 5'-monophosphate in human tissues.
Uchida M; Brown N; Ho DH
Anticancer Res; 1990; 10(3):779-83. PubMed ID: 2142396
[TBL] [Abstract][Full Text] [Related]
36. [The mRNA expression of platelet-derived endothelial cell growth factor of bladder transitional cell carcinoma and its relation to invasiveness].
Li G; Zhang YF; Ding Q; Wen DG; Yan CY
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):30-2. PubMed ID: 15059350
[TBL] [Abstract][Full Text] [Related]
37. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
38. Distribution of thymidine phosphorylase activity in gastric carcinoma and adjacent normal gastric tissue.
Sugiyama A; Maruta F; Tsuzuki S; Murakami M; Kawasaki S
Hepatogastroenterology; 2002; 49(48):1734-6. PubMed ID: 12397781
[TBL] [Abstract][Full Text] [Related]
39. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
40. [Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues].
Uchida M; Kamiya K; Yoshimura T; Sasaki K; Tsutani H; Nakamura T; Ho DH
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):990-6. PubMed ID: 2167917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
